Navigation Links
PAREXEL International Reports Second Quarter Fiscal Year 2013 Results
Date:1/29/2013

BOSTON, Jan. 29, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) today reported financial results for the second quarter of Fiscal Year 2013, which ended on December 31, 2012. 

For the three months ended December 31, 2012 consolidated service revenue increased by 26.7% to $422.1 million compared with $333.2 million in the prior year period.
Excluding the negative impact from foreign exchange movements in the current quarter of $2.8 million, revenue increased 27.5%.  Newly-acquired Liquent, Inc. (Liquent) contributed $0.4 million to revenue in the quarter.  Operating income as reported under Generally Accepted Accounting Principles (GAAP) totaled $31.4 million, or 7.4% of service revenue, in the second quarter of Fiscal Year 2013, as compared with $22.6 million, or 6.8% of service revenue, in the comparable quarter of the prior year.  GAAP net income for the quarter totaled $21.3 million, or $0.36 per diluted share, compared with a GAAP net income of $12.9 million, or $0.21 per diluted share, for the quarter ended December 31, 2011. 

The financial results of the December quarter in the current and prior periods each included special items, as detailed in the financial charts within this press release.  Excluding the impact of these special items, adjusted operating income in the second quarter of Fiscal Year 2013 was $32.1 million, or 7.6% of service revenue.  Excluding the impact of these special items, adjusted operating income in the second quarter of Fiscal Year 2012 was $23.8 million, or 7.1% of service revenue.  Adjusted net income in the current and prior periods (which excludes the special items referenced above) was $24.5 million, or $0.41 per diluted share in the quarter ended December 31, 2012, and was $13.9 million, or $0.23 per diluted share in the quarter ended December 31, 2011. 


'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
2. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
3. Parexel Invites Public To Listen To Live Webcast Of Its Investor Day May 31, 2012
4. PAREXEL Chairman And CEO To Ring The Bell At The NASDAQ Stock Market Opening
5. PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day
6. PAREXEL International To Present At NASDAQ OMX Investor Conference
7. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2012 Earnings Release and Conference Call
8. PAREXEL And Korea Drug Development Fund Announce Alliance To Accelerate Global Drug Development And Commercialization
9. PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies
10. PAREXEL Strengthens Outcomes Research Capabilities To Help Biopharma Meet Commercialization Goals
11. PAREXEL International to Present at Robert Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2, 2014 ... 2014 präsentierte GARFIELD-AF-Register bietet einen Einblick ... schlaganfallgefährdeten Patienten in der klinischen Praxis ... Daten der nahezu 12.500 im ... unabhängigen Forschungsinitiative zur Untersuchung von Vorhofflimmern, ...
(Date:9/2/2014)... , September 2, 2014 ... ESC CONGRESS 2014 provide insight into treatment and ... everyday clinical practice --   Data ... Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF), an ... stroke prevention strategies for atrial fibrillation (AF) patients ...
(Date:9/2/2014)... Pa. , Sept. 2, 2014 Particle ... adds to its investment in development and manufacturing capabilities ... to Karl Mueller , Particle Sciences, Associate Director ... nice pace adding clean room square footage, equipment and ... our clients.  The company now has over 6000ft 2 ...
Breaking Medicine Technology:Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 2Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 3Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 4Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 5Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 6Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 7Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 8Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 9Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 10Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 11Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 2Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 3Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 4Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 5Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 6Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 7Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 8Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 9Particle Sciences Expands Drug Eluting Device Capabilities and Overall Clinical Trial Manufacturing Resources 2
(Date:9/2/2014)... Recently, Top 10 Best SEO ... announced that JustHost ( http://www.justhost.com/track/seohosts ) and BlueHost ... “The hosting suppliers we recommend are the best ... hosting features, uptime and server speed with top-level ... Hosting says. “We believe that BlueHost and JustHost ...
(Date:9/2/2014)... 02, 2014 Friendship Village of ... “This creates a contemporary marketing presence and ... its parent organization, Friendship Senior Options,” said Stephen ... Options. “By changing the logo, we are making ... to seniors and their families.” , Friendship Village ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 The Wm. Jennings ... fair and public town hall meeting for Veterans and their ... at the outreach fair to provide Veterans with valuable healthcare ... “The town hall will provide a forum where we can ... programs.” , The outreach fair will be held 4:45 p.m. ...
(Date:9/2/2014)... patients treated with lumpectomy followed by radiation therapy ... mastectomy, according to a large study conducted by ... and the Cancer Prevention Institute of California. , ... with the disease is the first to directly ... surgical interventions: bilateral mastectomy (the removal of both ...
(Date:9/2/2014)... the groundwork for their own spread throughout the body ... tumor-welcoming signals, according to a new report by Johns ... of Nature Communications , the researchers describe animal ... signaling molecules released by breast cancer cells. These molecules ... lymph nodes to produce proteins called CCL5 and VEGF. ...
Breaking Medicine News(10 mins):Health News:Friendship Village of Schaumburg In Illinois Announces New Logo 2Health News:Breast cancer patients with bilateral mastectomy don't have better survival rates 2Health News:Breast cancer patients with bilateral mastectomy don't have better survival rates 3Health News:Breast cancer patients with bilateral mastectomy don't have better survival rates 4Health News:‘Prepped’ by tumor cells, lymphatic cells encourage breast cancer cells to spread 2
... Reporter , MONDAY, Oct. 25 (HealthDay News) -- Heavy ... developing Alzheimer,s disease or another dementia, a large new study ... in midlife had more than a 100 percent increase in ... Rachel A. Whitmer, a research scientist in Kaiser Permanente,s Division ...
... of hormone therapy and radiation have a substantially improved chance ... according to interim results of the largest randomized study of ... at the 52nd Annual Meeting of the American Society for ... men with high-risk prostate cancer in the United States, the ...
... Discovery Fund (LSDF) today announced a $5 million grant ... and commercialize new drugs to treat a variety of ... and the sales of drugs in the marketplace, an ... a new non-profit initiative to advance the life sciences ...
... sustainably using stem cells derived from trees, a study suggests. ... yew tree whose bark is a natural source of the ... be produced on a commercial scale at low cost, with ... development say the drug treatment currently used on lung, ...
... 25 (HealthDay News) -- The arteries of obese children have ... disease, according to a new study. Canadian researchers evaluated ... children. The obese children had abnormal results on an ultrasound ... fast blood flowed through the body. Of special note ...
... Oct. 25 (HealthDay News) -- Colorectal cancer screening among ... arrange for the procedure during a mammography visit, a ... inadequate in minority communities in the United States, many ... Memorial Sloan-Kettering Cancer Center in New York City. ...
Cached Medicine News:Health News: Heavy Smoking Linked to Alzheimer's in Study 2Health News: Heavy Smoking Linked to Alzheimer's in Study 3Health News:Adding radiation to hormone therapy for prostate cancer treatment will increase survival chances 2Health News:Life Sciences Discovery Fund to support drug discovery, foster new R&D initiative 2Health News:Life Sciences Discovery Fund to support drug discovery, foster new R&D initiative 3Health News:Plant stem cells could be fruitful source of low-cost cancer drug 2Health News:Arteries of Obese Kids Aging Prematurely: Study 2Health News:Mammogram Visit a Good Time to Arrange Colonoscopy: Study 2
PowerMed is a billing software....
MedLook 3.0 is a medical billing software....
Managed care is a billing and tracking system....
... billing program dealing with the clerical aspects ... standard Health Insurance Claim Form, or CMS-1500. ... the internet. This means that you can ... home or work without using a web ...
Medicine Products: